|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date † | September 12, 2005 | ||||||||
| Last Updated Date | February 3, 2009 | ||||||||
| Start Date † | January 2000 | ||||||||
| Current Primary Outcome Measures † | |||||||||
| Original Primary Outcome Measures † | |||||||||
| Change History | Complete list of historical versions of study NCT00184210 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures † | |||||||||
| Original Secondary Outcome Measures † | |||||||||
| Descriptive Information | |||||||||
| Brief Title † | Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue | ||||||||
| Official Title † | HR MAS MR Spectroscopy of Breast Cancer Tissue | ||||||||
| Brief Summary | Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, as histopathology. The MR spectral profiles are compared to clinical findings as the patients diagnosis, lymph node status and tumor size. |
||||||||
| Detailed Description | |||||||||
| Study Phase | |||||||||
| Study Type † | Observational | ||||||||
| Study Design † | Cohort, Cross-Sectional | ||||||||
| Condition † | Breast Neoplasms | ||||||||
| Intervention † | |||||||||
| Study Arms / Comparison Groups | |||||||||
| Publications * |
|
||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status † | Recruiting | ||||||||
| Enrollment † | 1000 | ||||||||
| Completion Date | |||||||||
| Primary Completion Date | |||||||||
| Eligibility Criteria † | Inclusion Criteria: - Palpable breast cancer lesion |
||||||||
| Gender | Female | ||||||||
| Ages | 18 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts †† |
|
||||||||
| Location Countries † | Norway | ||||||||
| Expanded Access Status | |||||||||
| Administrative Information | |||||||||
| NCT ID † | NCT00184210 | ||||||||
| Responsible Party | Norwegian University of Science and Technology, NTNU | ||||||||
| Secondary IDs †† | |||||||||
| Study Sponsor † | Norwegian University of Science and Technology | ||||||||
| Collaborators †† |
|
||||||||
| Investigators † |
|
||||||||
| Information Provided By | Norwegian University of Science and Technology | ||||||||
| Verification Date | February 2009 | ||||||||
|
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |
|||||||||
